These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3490828)

  • 1. 7 alpha-formylamino substituent confers beta-lactamase-inactivating potency on 1-oxacephalosporins.
    Murakami K; Doi M; Yoshida T
    Antimicrob Agents Chemother; 1986 Sep; 30(3):447-52. PubMed ID: 3490828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1981 Jan; 19(1):1-7. PubMed ID: 6454378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of formylamino- and methoxy-substituted beta-lactam antibiotics with beta-lactamases.
    Okonogi K; Sugiura A; Kuno M; Ono H; Harada S; Higashide E
    J Antibiot (Tokyo); 1985 Nov; 38(11):1555-63. PubMed ID: 3878359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1985 May; 27(5):727-32. PubMed ID: 3874595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
    Murakami K; Takasuka M; Motokawa K; Yoshida T
    J Med Chem; 1981 Jan; 24(1):88-93. PubMed ID: 6451699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative beta-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1979 Sep; 32(9):909-14. PubMed ID: 315938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephabacins, new cephem antibiotics of bacterial origin. IV. Antibacterial activities, stability to beta-lactamases and mode of action.
    Nozaki Y; Okonogi K; Katayama N; Ono H; Harada S; Kondo M; Okazaki H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1555-65. PubMed ID: 6335505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.
    Fukasawa M; Noguchi H; Okuda T; Komatsu T; Yano K
    Antimicrob Agents Chemother; 1983 Feb; 23(2):195-200. PubMed ID: 6601470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam: an oxa-beta-lactam antibiotic that inactivates beta-lactamases.
    Labia R
    Rev Infect Dis; 1982; 4 Suppl():S529-35. PubMed ID: 6218563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and substituent effects on antibacterial activity, alkaline hydrolysis rates, and infrared absorption frequencies of some cephem analogues related to latamoxef (moxalactam).
    Narisada M; Yoshida T; Ohtani M; Ezumi K; Takasuka M
    J Med Chem; 1983 Nov; 26(11):1577-82. PubMed ID: 6631914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
    Yoshida T; Matsuura S; Mayama M; Kameda Y; Kuwahara S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):302-12. PubMed ID: 6448572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
    Minamimura M; Taniyama Y; Inoue E; Mitsuhashi S
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Sep; 24(3):313-20. PubMed ID: 6605718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of a series of beta-lactam-based prodrugs.
    Hakimelahi GH; Shia KS; Xue C; Hakimelahi S; Moosavi-Movahedi AA; Saboury AA; Khalafi-Nezhad A; Soltani-Rad MN; Osyetrov V; Wang K; Liao JH; Luo FT
    Bioorg Med Chem; 2002 Nov; 10(11):3489-98. PubMed ID: 12213463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K; Inoue E; Mitsuhashi S
    Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.